World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
42245
World Ranking
8829
National Ranking
4549

Overview

John P. Leonard is affiliated with Cornell University in the United States and has made significant contributions in the field of medicine, focusing particularly on pathology and forensic medicine, oncology, genetics, molecular biology, and neurology.

Their main research topics include lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, CAR-T cell therapy research, CNS lymphoma diagnosis and treatment, viral-associated cancers and disorders, lung cancer treatments and mutations, and acute lymphoblastic leukemia research.

John P. Leonard has authored numerous papers, including recent publications such as:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures, 2021, Cancer Discovery
  • CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema, 2024, New England Journal of Medicine
  • Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma, 2024, New England Journal of Medicine
  • Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001, 2020, Journal of Clinical Oncology

The regular publication venues for their work include Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology, and Clinical Lymphoma Myeloma & Leukemia.

Frequent co-authors collaborating with John P. Leonard are:

  • Brad S. Kahl
  • Nancy L. Bartlett
  • Jonathan W. Friedberg
  • Peter Martin
  • Sarah C. Rutherford

Their publication record spans multiple subfields, with notable activity in pathology and forensic medicine, oncology, genetics, molecular biology, and neurology. The majority of their research is categorized under medicine, where they have contributed to over 340 publications.

Best Publications

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

    Anas Younes;Nancy L Bartlett;John P Leonard;Dana A Kennedy

  • CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

    Julian D. Gillmore;Ed Gane;Jorg Taubel;Justin Kao

  • Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

    Wyndham H Wilson;Owen A O'Connor;Myron S Czuczman;Ann S LaCasce

  • Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production

    John P. Leonard;Matthew L. Sherman;Gerald L. Fisher;Lynn J. Buchanan

  • Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

    Jonathan W. Friedberg;Jeff Sharman;John Sweetenham;Patrick B. Johnston

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    Richard L. Piekarz;Robin Frye;Maria Turner;John J. Wright

  • Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

    M. S. Kaminski;A. D. Zelenetz;O. W. Press;M. Saleh

  • Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

    J P Leonard;K E Waldburger;S J Goldman

  • Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.

    Bruce D. Cheson;John P. Leonard

  • PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin’s Disease

    Lale Kostakoglu;Morton Coleman;John P. Leonard;Ichiei Kuji

  • The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

    Nichola Cooper;Roberto Stasi;Susanna Cunningham-Rundles;Michael A. Feuerstein

  • Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

    Peter Martin;Amy Chadburn;Paul Christos;Karen Weil

  • Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor

    Vincent Ling;Paul W. Wu;Heather F. Finnerty;Kevin M. Bean

  • Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

    A. Goy;S. H. Bernstein;B. S. Kahl;B. Djulbegovic

  • Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

    Jia Ruan;Peter Martin;Richard R. Furman;Shing M. Lee

  • Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.

    Michael J. Eppihimer;Jason Gunn;Gordon J. Freeman;Edward A. Greenfield

  • Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

    Nancy L. Bartlett;Wyndham H. Wilson;Sin Ho Jung;Eric D. Hsi

  • Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study.

    Brad S. Kahl;Nancy L. Bartlett;John P. Leonard;Ling Chen

Frequent Co-Authors

Morton Coleman
Morton Coleman Cornell University
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Bruce D. Cheson
Bruce D. Cheson Georgetown University
Selina Chen-Kiang
Selina Chen-Kiang Cornell University
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Ian W. Flinn
Ian W. Flinn Sarah Cannon Research Institute
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Paul J. Christos
Paul J. Christos Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean becoming a physician. There are numerous online degree pathways designed to help students and working professionals advance in the healthcare sector. For those interested in healthcare leadership, online mha programs cahme accredited offer rigorous, recognized curriculums that prepare graduates for high-level administrative roles.

Nursing professionals seeking a faster route to career advancement can explore options like the rn to bsn without clinicals programs. These allow RNs to earn their BSN degrees online, often without on-site clinical requirements, which can be ideal for those needing flexibility.

Advanced nursing degrees are also available online, enabling nurses to move into leadership, education, or specialized clinical roles. For those wanting to earn a doctorate in the shortest possible time, the quickest dnp program options provide accelerated completion. Alternatively, nurses looking for less intensive routes might prefer the online dnp programs that balance academic requirements with manageable workloads.

Best Scientists Citing John P. Leonard

Trending Scientists

Recently Published Articles